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E-mail: ebottieau@itg.beTraditionally, microscopy has been the major tool used for
diagnosing parasitic infections. For clinicians confronted with
patients suspected of having infectious diseases, the contribu-
tion of this venerable technique is often invaluable. However, it
also has numerous limitations, including cumbersomeness, a
considerable need for expertise, and the lack of sensitivity and
reproducibility [1].
To circumvent these long-recognized pitfalls, new technol-
ogies have emerged, often driven by advances in other micro-
biological disciplines, such as virology and bacteriology. The
most successful advance in the past two decades has been the
use of nucleic acid ampliﬁcation tests (NAATs), mainly PCR,
which have revolutionized many aspects of the clinical care of
infectious diseases. In parallel, in low-resource settings where
molecular technologies remain out of ﬁnancial and technical
reach, the development of simple and cheap rapid diagnostic
tests (RDTs), mostly based on immunochromatography, has
substantially improved the ﬁeld management of important
conditions such as human immunodeﬁciency virus infection and
malaria [2]. More recently, proteomic approaches have
emerged, mainly using mass spectrometry platforms, to identify
biomarkers reﬂecting the complex host–pathogen interactions,
in order to better distinguish infection and disease, or active
and cured infection [1].
Incorporation of these new methods, and in particular the
NAATs, in clinical practice seems to be slower in the ﬁeld of
parasitology than in other disciplines. Although they were often
found to be more accurate and rapid than conventional mi-
croscopy, NAATs used for detecting protozoan and helminths
face speciﬁc technical issues (e.g. regarding DNA extraction in
stools), lack standardization, and are difﬁcult to adequately
evaluate, both in high-income settings, where numbers of
infected patients are low, and in tropical areas, where this
technology is demanding. There are, however, notableMicrobiol Infect 2015; 21: 518–519
nical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infect
p://dx.doi.org/10.1016/j.cmi.2015.04.008exceptions, such as malaria and leishmaniasis, where species-
speciﬁc diagnosis by PCR has progressively become the
cornerstone of clinical management in travel medicine [3]. Also,
important efforts are being made to make molecular technology
applicable to the most peripheral tropical areas [4], in parallel
with the further development of RDTs for additional parasitic
diseases [5] and challenging syndromes [6,7].
Perhaps the main reason for the slow adoption of these new
diagnostic tools in clinical practice is that their added value as
compared with microscopy is not yet fully appreciated. Clini-
cians may feel uncomfortable with new technologies that are
perceived as rather expensive when the indications for their
complementary or combined use with conventional methods
have not been completely clariﬁed. We therefore hope that this
themed issue is timely and useful, at least for some major
parasitic infections in travel and tropical settings.
In the ﬁrst review [8], van Lieshout and Roestenberg share
with the readers their experience in The Netherlands, where
multiplex real-time PCR is progressively supplanting conven-
tional microscopy in the ﬁrst-line work-up of enteric syn-
dromes. They propose an innovative reorganization of the tasks
of routine laboratories for the diagnosis of parasitic enteritis in
low-risk populations. They also discuss the clinical conse-
quences and potential drawbacks for speciﬁc groups of patients
(travellers, migrants, and immunosuppressed individuals) who
might harbour a wider spectrum of parasites, and call for good
collaboration between microbiologists and clinicians to main-
tain appropriate conventional testing whenever necessary. In
the second review [9], Utzinger et al. consider in detail the new
diagnostic tools for schistosomiasis, and insist on the urgent
need for the use of highly sensitive assays, i.e. NAATs or RDTs,
not only for travellers, but also for the increasing number of
individuals who are repeatedly exposed to mass drug adminis-
tration with praziquantel in tropical settings, as low-level
infection is the rule in both of these groups. Finally, Buonf-
rate et al. provide a very comprehensive review of the diag-
nostic issues for strongyloidiasis, one of the most challenging
parasitic infections, and propose robust guidance on the most
appropriate tests to use in different epidemiological and clinicalious Diseases. Published by Elsevier Ltd. All rights reserved
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clinical parasitology is also evolving, and that, if the pace seems
slower, it is mostly because knowledge gaps still persist
regarding the best clinical use of new diagnostic tools in settings
as different as travel clinics and tropical health systems.
Concerted and close research collaboration between micro-
biologists and infectious disease specialists is the only way to
rapidly deal with these important issues.Transparency declarationThe author has no conﬂict of interest related to the present
article.References[1] Yansouni CP, Merckx J, Libman MD, Ndao M. Recent advances in
clinical parasitology diagnostics. Curr Infect Dis Rep 2014;16:434.Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology[2] Maltha J, Gillet P, Jacobs J. Malaria rapid diagnostic tests in endemic
settings. Clin Microbiol Infect 2013;19:399–407.
[3] Blum J, Buffet P, Visser L, Harms G, Bailey MS, Caumes E, et al.
LeishMan recommendations for treatment of cutaneous and mucosal
leishmaniasis in travelers, 2014. J Travel Med 2014;21:116–29.
[4] Mitashi P, Hasker E, Ngoyi DM, Pyana PP, Lejon V, Van der Veken W,
et al. Diagnostic accuracy of Loopamp Trypanosoma brucei detection kit
for diagnosis of human African trypanosomiasis in clinical samples.
PLoS Negl Trop Dis 2013;7:e2504.
[5] Buscher P, Gilleman Q, Lejon V. Rapid diagnostic test for sleeping
sickness. N Engl J Med 2013;368:1069–70.
[6] Chappuis F, Alirol E, D’Acremont V, Bottieau E, Yansouni CP. Rapid
diagnostic tests for non-malarial febrile illness in the tropics. Clin
Microbiol Infect 2013;19:422–31.
[7] Yansouni CP, Bottieau E, Lutumba P, Winkler AS, Lynen L, Büscher P,
et al. Rapid diagnostic tests for neurological infections in central Africa.
Lancet Infect Dis 2013;13:546–58.
[8] van Lieshout L, Roestenberg M. Clinical consequence of new diagnostic
tools for intestinal parasites. Clin Microbiol Infect 2015;21:520–8.
[9] Utzinger J, Becker SL, van Lieshout L, van Dam GJ, Knopp S. New
diagnostic tools in schistosomiasis. Clin Microbiol Infect 2015;21:
529–42.
[10] Buonfrate D, Formenti F, Perandin F, Bisofﬁ Z. Novel approaches to
the diagnosis of Strongyloides stercoralis. Clin Microbiol Infect 2015;21:
543–52.and Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 518–519
